Companies / Ligand Pharmaceuticals Inc / Activity
Activity — Ligand Pharmaceuticals Inc
9 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 14, 2026 | Davis Todd C CEO | Other | Common Stock | $2.87M | -16K -7.30% | 197,985 0.99% of shares | low |
| Feb 14, 2026 | Davis Todd C CEO | Other | Common Stock | $1.50M | -8K -4.49% | 173,941 0.87% of shares | low |
| Feb 15, 2026 | Davis Todd C CEO | Other | Common Stock | $782.2K | -4K -2.17% | 191,691 0.96% of shares | low |
| Feb 15, 2026 | Davis Todd C CEO | Other | Common Stock | $515.6K | -3K -1.46% | 188,886 0.95% of shares | low |
| Feb 15, 2026 | Davis Todd C CEO | Other | Common Stock | $374.8K | -2K -1.03% | 195,946 0.98% of shares | low |
| Mar 2, 2026 | Davis Todd C CEO | Grant | Common Stock | $0 | +10K +5.56% | 199,381 1.00% of shares | low |
| Feb 14, 2026 | Davis Todd C CEO | Grant | Common Stock | $0 | +40K +22.79% | 213,585 1.07% of shares | low |
| Feb 14, 2026 | Davis Todd C CEO | Grant | Common Stock | $0 | +21K +12.88% | 182,119 0.91% of shares | low |
| Mar 2, 2026 | Davis Todd C CEO | Grant | Employee Stock Option (right to buy) | — | +50K | 50,058 0.25% of shares | low |